期刊文献+

脱细胞异体真皮在尿瘘修补中的临床疗效分析

Clinical analysis of human acellular allogeneic dermis in the repair of urinary fistula
下载PDF
导出
摘要 目的探讨脱细胞异体真皮(HADM)在尿瘘修补中的临床疗效。方法回顾性分析厦门大学附属第一医院2021年6月—2022年11月收治的12例女性复杂性膀胱阴道瘘采用HADM修补患者的临床资料。患者年龄38~56岁,平均47.3岁;体质量指数(BMI)16.6~25.2,平均21.3。12例患者术中经阴道途径均采用HADM填补修补瘘口。术中将HADM置入阴道、膀胱壁瘘口之间。结果12例手术均顺利完成。术后阴道漏尿停止,保留尿管2周,术后随访1~16个月,未见复发。所有病例均未发生手术并发症。结论在复杂性膀胱阴道瘘手术治疗中,经阴道采用HDMA修补瘘口,对患者创伤小、恢复时间短、成功率高,是比较理想的修补复杂膀胱阴道瘘的方法。 Objective To investigate the clinical efficacy of human acellular allogeneic dermis(HADM)in the repair of urinary fistula.Methods The clinical data of 12 female patients with complex vesicovaginal fistula treated during Jun.2021 and Nov.2022 were retrospectively analyzed.The patients average age was 47.3 years,ranging from 38 to 56 years.The body mass index(BMI)ranged from 16.6 to 25.2,with an average of 21.3.HADM was inserted between vagina and bladder wall fistula to repair fistula in all 12 patients.Results All operations were successful.After the operation,the vaginal urine leakage stopped and the urinary tube was retained for 2 weeks.During the postoperative follow-up of 1 to 16 months,no recurrence or complication were observed.Conclusion Transvaginal HDMA is an ideal surgical method in the treatment of complex vesicovaginal fistula,which has advantages of small trauma,fast recovery and high success rate.
作者 刘菲 陈跃东 曾彦恺 LIU Fei;CHEN Yuedong;ZENG Yankai(Department of Urology,First Affiliated Hospital of Xiamen University,Xiamen 361003,China)
出处 《现代泌尿外科杂志》 CAS 2023年第11期933-935,941,共4页 Journal of Modern Urology
基金 福建省自然科学基金项目(No.2020J011249) 福建省卫健委创新基金项目(No.2020CXB046)。
关键词 脱细胞异体真皮 复杂性膀胱阴道瘘 阴道漏尿 经阴道瘘口修补 human acellular allogenic dermis transvaginal repair of urinary fistula complex vesicovaginal fistula vaginal urine leakage
  • 相关文献

参考文献3

二级参考文献12

  • 1张金明,崔永言,潘淑娟,梁伟强,陈小萱.应用脱细胞异体真皮植入Bucks筋膜下加大阴茎[J].中华整形外科杂志,2004,20(6):418-420. 被引量:20
  • 2林健,郝金瑞,金杰,邓庶民,胡杰,那彦群.人同种异体真皮脱细胞基质在尿道重建中的临床应用[J].中华医学杂志,2005,85(15):1057-1059. 被引量:26
  • 3[1]Angioli R,Penalver M,Muzii L,et al.Guidelines of how to manage vesicovaginal fistula[J].Crit Rev Oncol Hematol,2003,48(3):295-304.
  • 4[2]Sievert K,Bakircioglu M,Nunes L,et al.Homologous acellular matrix graft for urethral reconstruction in the rabbit:histological and functional evaluation[J].J Urol,2000,163(6):1958-1965.
  • 5[3]Shokeir A,Osman Y,El-sherbinyM,et al.Acellular matrix tube for canine urethral rep lacement:is it fact or fiction?[J].Eur Urol,2003,44(5):603-609.
  • 6[6]Haynes DS,Vos JD,Labadie RF.Acellular allograft dermal matrix for tympanoplasty[J].Curr Opin Otolaryngol Head Neck Surg,2005,13(5):283-286.
  • 7[7]Ophof R,Mahha JC,Von den Hoff JW,et al.Histologic evaluation of skin-derived and collagen-based substrates implanted in palatal wounds[J].Wound Repair Regen,2004,12(5):528-538.
  • 8[8]Downey TJ,Champeaux AL,Silva AB.AlloDerm tympanoplasty of tympanic membrane perforations[J].Am J Otolaryngo,2003,24(1):6-13.
  • 9Goh JT. A new classification for female genital tract fistula [J]. Aust NZJ Obstet Gynecol, 2004,44(6) :502 -504.
  • 10部分省 市 自治区子宫脱垂 尿瘘防治科研协作组.有关尿瘘防治的意见.中国医刊,1979,:7-8.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部